 |
 |
 |
| |
Mikael Ørum,
Partner |
 |
 |
| |
Peter
Damsbo, MD,
Partner |
 |
 |
| |
Robert L. Buchanan , PhD,
Attorney at Law, Partner |
 |
 |
| |
Dede Willis, BSc, MBA,
Partner |
 |
 |
| |
Christina Wagner, PhD, Partner |
 |
 |
| |
Ravi Vinayak, PhD,
Partner |
 |
 |
| |
Mirko
Stange, PhD,
Partner |
 |
 |
| |
Madeline
Yap, PhD,
Partner |
 |
 |
| |
Konstantinos
Alevizopoulos, PhD,
Partner |
 |
 |
| |
Spencer Ma MBA, FCPA, ACIS ,
Partner |
 |
 |
| |
Pieter
Telleman, PhD, MBA,
Senior Advisor |
 |
 |
| |
Lars Hedbys,
M Sc, PhD,
Senior Advisor |
 |
 |
|
 |
| |
| |
|
|
Our Team
Ravi
Vinayak, PhD |
Partner
Dr. Ravi Vinayak joined Ventac Partners in August 2006.
Prior to this he was running a successful consulting business serving
several Life Sciences organizations across the globe sharing his
vast knowledge and experience in technology transactions, alliance
management, licensing, strategic planning and negotiations.
Dr. Vinayak started his industry career as a Scientist at Applied
Biosystems where he spent more than sixteen years in increasing responsibilities
eventually leading to a role as a business development executive
where he led, managed and directed interdisciplinary team effort
in conducting business analysis identifying clear and compelling
cases for licensing, partnering, or acquisition of new technologies.
Dr. Vinayak obtained his Ph.D. from the University of Alberta,
Canada, and did his post-doctoral research at The California Institute
of Technology, California. Ravi has authored over 40 publications
and patents and contributed to several book chapters relating to
Nucleic Acids Chemistries and technologies.
|
|

Ravi Vinayak, PhD
Partner
|
|
|